PULSE BIOSCIENCES, INC. PLSE
PULSE BIOSCIENCES, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $350,000 | $0 | $0 | $700,000 | $1.4M | $0 | — | — | — | — |
| R&D expense | $44.7M | $32.3M | $27.8M | $20.8M | $28.6M | $26.4M | $25.0M | $17.3M | $9.6M | $5.5M |
| SG&A expense | $32.0M | $23.9M | — | — | — | — | — | — | — | — |
| Operating income | -$76.9M | -$56.3M | -$43.6M | -$58.1M | -$63.0M | -$50.0M | -$48.0M | -$37.5M | -$25.6M | -$9.5M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — |
| Net income | -$72.8M | -$53.6M | -$42.2M | -$58.5M | -$63.7M | -$49.9M | -$47.0M | -$37.5M | -$25.6M | -$9.5M |
| Operating cash flow | -$54.1M | -$36.3M | -$33.0M | -$47.0M | -$54.1M | -$35.4M | -$34.2M | -$23.9M | -$11.1M | -$8.1M |
| Free cash flow | -$54.4M | -$36.5M | -$33.2M | -$47.4M | -$54.5M | -$35.8M | -$34.8M | -$24.2M | -$13.6M | -$8.1M |
| Cash & equivalents | $80.7M | $118.0M | $44.4M | $61.1M | $44.4M | $12.5M | $6.9M | $51.1M | $3.4M | $2.1M |
| Inventory | $136,000 | $0 | — | $0 | $5.8M | — | — | — | — | — |
| Total assets | $94.5M | $132.5M | $59.2M | $77.9M | $59.2M | $41.3M | $41.9M | $70.6M | $49.8M | $26.3M |
| Total liabilities | $13.9M | $17.6M | $14.8M | $80.1M | $14.8M | $18.4M | $11.2M | $4.3M | $3.8M | $1.0M |
| Shareholders' equity | $80.7M | $114.9M | $44.4M | -$2.2M | $44.4M | $22.9M | $30.7M | $66.3M | $46.0M | $25.3M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | -100.0% | -50.6% | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.